Charles River Laboratories International (CRL) Change in Receivables (2009 - 2026)

Charles River Laboratories International has reported Change in Receivables for 18 years, with the latest figure at $21.8 million in Q2 2026.

• On a quarterly basis, Change in Receivables rose 300.83% year-over-year to $21.8 million in Q2 2026; TTM through Jun 2026 was $32.9 million, a 1705.27% increase from a year earlier, with the FY2025 full-year figure at -$35.7 million, down 65.36% from the prior year.
• Change in Receivables was $21.8 million for Q2 2026 at Charles River Laboratories International, down from $65.3 million in the prior quarter.
• The five-year high for Change in Receivables was $65.3 million in Q1 2026, with the low at -$27.6 million in Q4 2025.
• Average Change in Receivables over 5 years is $11.9 million, with a median of $12.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables surged 1135.05% in 2022, then slumped 734.27% in 2025.
• Over 5 years, Change in Receivables stood at -$23.6 million in 2022, then slipped by 8.68% to -$25.6 million in 2023, then jumped by 87.09% to -$3.3 million in 2024, then plunged by 734.27% to -$27.6 million in 2025, then surged by 178.95% to $21.8 million in 2026.
• The last three Change in Receivables figures came in at $21.8 million (Q2 2026), $65.3 million (Q1 2026), and -$27.6 million (Q4 2025), per Business Quant data.